Electrophysiology Ablation Catheters Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Electrophysiology Ablation Catheters Pipeline Market Report Overview

An electrophysiology ablation catheter contains an electrode on one end which emits RF waves to destroy a small area of heart tissue in the abnormal conduction pathway, blocking further channeling of the impulses causing the heart’s abnormal rhythm. EP Ablation is applicable for a wide variety of arrhythmias and has an extremely high success rate with low rates of complication and recurrence.

The electrophysiology ablation catheters pipeline market research report provides comprehensive information about the electrophysiology ablation catheters pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials that are in progress.

Key Segments ·        Advanced Ablation Catheters

·        Irrigated tip RF Ablation Catheters

·        Cryoablation Catheters

·        Conventional Radio Frequency Ablation Catheters

·        Laser Ablation Catheters

·        Standard Ablation Catheters

Key Territories ·        The US

·        Europe

·        China

·        Australia

·        Japan

·        Israel

Key Regulatory Paths ·        CE

·        510(k)

·        PMA

·        NMPA

·        TGA

·        Shonin

Leading Companies ·        Acotec Scientific Co Ltd

·        Adagio Medical Inc.

·        Apama Medical Inc

·        APT Medical Inc

·        Biosense Webster Inc

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Electrophysiology Ablation Catheters Pipeline Market by Segments

The key segments in the electrophysiology ablation catheters pipeline market are advanced ablation catheters, irrigated tip RF ablation catheters, cryoablation catheters, conventional radiofrequency ablation catheters, laser ablation catheters, and standard ablation catheters. As of September 2023, advanced ablation catheters have a higher number of pipeline products.

Electrophysiology Ablation Catheters Pipeline Market Analysis by Segments, 2023 (%)

Electrophysiology Ablation Catheters Pipeline Market Analysis by Segments, 2023 (%)

Buy the Full Report for More Segment Insights into the Electrophysiology Ablation Catheters Pipeline Market

Download A Free Report Sample

Electrophysiology Ablation Catheters Pipeline Market Segmentation by Territories

Some of the key territories in the electrophysiology ablation catheters market are the US, Europe, China, Australia, Japan, Israel, Macau, New Zealand, and Hong Kong. As of September 2023, the US has the highest number of pipeline products.

Electrophysiology Ablation Catheters Pipeline Market Analysis by Territories, 2023 (%)

Electrophysiology Ablation Catheters Pipeline Market Analysis by Territories, 2023 (%)

Buy the Full Report for More Territory Insights into the Electrophysiology Ablation Catheters Pipeline Market

Download A Free Report Sample

Electrophysiology Ablation Catheters Pipeline Market Segmentation by Regulatory Paths

Some of the key regulatory paths in the electrophysiology ablation catheter pipeline market are CE, 510(k), PMA, NMPA, TGA, Shonin, MDCO, and Ninsho. As of September 2023, CE is the most followed pathway for pipeline products in the market.

Electrophysiology Ablation Catheters Pipeline Market Analysis by Regulatory Paths, 2023 (%)

Electrophysiology Ablation Catheters Pipeline Market Analysis by Regulatory Paths, 2023 (%)

Buy the Full Report for More Regulatory Path Insights into the Electrophysiology Ablation Catheters Pipeline Market, Download A Free Report Sample

Electrophysiology Ablation Catheters Pipeline Market – Competitive Landscape

Some of the key companies in the electrophysiology ablation catheters pipeline market are Acotec Scientific Co Ltd, Adagio Medical Inc., Apama Medical Inc, APT Medical Inc, and Biosense Webster Inc. among others.

Acotec Scientific Co Ltd: Acotec Scientific Co Ltd, a subsidiary of Acotec Scientific Holdings Ltd, is a research and development firm that offers medical devices such as electro physiologic catheter, drug coated balloon, percutaneous transluminal angioplasty and vascular interventional treatments..

Biosense Webster Inc: Biosense Webster Inc (Biosense Webster), a subsidiary of Johnson & Johnson, is a medical device company that designs, manufactures, and markets cardiac arrhythmias products. The company’s products include ablation catheters, diagnostic catheters and access, ultrasound catheters, and 3D cardiac mapping.

Electrophysiology Ablation Catheters Pipeline Market Analysis by Companies, 2023

Electrophysiology Ablation Catheters Pipeline Market Analysis by Companies, 2023

Buy the Full Report for More Company Insights into the Electrophysiology ablation catheters Pipeline Market
Download A Free Report Sample

Segments Covered in the Report

Electrophysiology Ablation Catheters Pipeline Market Segments Outlook

  • Advanced Ablation Catheters
  • Irrigated tip RF Ablation Catheters
  • Cryoablation Catheters
  • Conventional Radio Frequency Ablation Catheters
  • Laser Ablation Catheters
  • Standard Ablation Catheters

Electrophysiology Ablation Catheters Pipeline Market Territories Outlook

  • The US
  • Europe
  • China
  • Australia
  • Japan
  • Israel

Electrophysiology Ablation Catheters Pipeline Market Regulatory Paths Outlook

  • CE
  • 510(k)
  • PMA
  • NMPA
  • TGA
  • Shonin

Scope

This report provides:

  • Extensive coverage of the electrophysiology ablation catheters under development.
  • Details of major pipeline products which include product description, licensing and collaboration details and other developmental activities.
  • Reviews of major players involved in the development of electrophysiology ablation catheters and lists all their pipeline projects.
  • Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
  • Provides key clinical trial data related to ongoing clinical trials specific to pipeline products.
  • Recent developments in the segment/industry.

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain a competitive advantage.
  • Identify and understand important and diverse types of electrophysiology ablation catheters under development.
  • Develop market-entry and market-expansion strategies.
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
  • In-depth analysis of the product’s current stage of development, territory, and estimated launch date.

Ablacon Inc
Acotec Scientific Co Ltd
Adagio Medical Inc.
Apama Medical Inc
APT Medical Inc
Biosense Webster Inc
BioTex Inc
Boston Scientific Corp
CardioFocus Inc
CardioNova Ltd
CathEffects LLC
CathRx Ltd
Cibiem, Inc.
Columbia University
Cordis Corp
CoreMap Inc
Coridea, LLC
CryoTherapeutics Gmbh
Epicardial Technologies Inc (Inactive)
Ethicon US LLC
Farapulse Inc
FocusStart LLC
Galvanize Therapeutics Inc
Hansen Medical Inc (Inactive)
Hyblate Medical
Imricor Medical Systems Inc
Interventional Imaging, Inc.
Iowa Approach Inc.
Japan Lifeline Co Ltd
Maestro Heart SA
Medlumics SL
Medtronic Plc
MedWaves Inc
MicroPort Scientific Corp
Northwestern University
Novasentis Inc
OrbusNeich
SCR, Inc.
Seattle Children's Hospital
Shanghai HeartCare Medical Technology Co Ltd
Shanghai MicroPort EP MedTech Co Ltd
St. Jude Medical LLC
Stereotaxis Inc
University of Arkansas at Little Rock
University of Michigan
University of Rochester
University of Texas Medical Branch at Galveston
Vanderbilt University
Vimecon GmbH
Vivonics Inc
Voyage Medical (Inactive)

Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 6

|1.2 List of Figures 11

2 Introduction 12

2.1 Electrophysiology Ablation Catheters Overview 12

3 Products under Development 13

3.1 Electrophysiology Ablation Catheters – Pipeline Products by Stage of Development 13

3.2 Electrophysiology Ablation Catheters – Pipeline Products by Segment 14

3.3 Electrophysiology Ablation Catheters – Pipeline Products by Territory 15

3.4 Electrophysiology Ablation Catheters – Pipeline Products by Regulatory Path 16

3.5 Electrophysiology Ablation Catheters – Pipeline Products by Estimated Approval Date 17

3.6 Electrophysiology Ablation Catheters – Ongoing Clinical Trials 18

4 Electrophysiology Ablation Catheters – Pipeline Products under Development by Companies 19

4.1 Electrophysiology Ablation Catheters Companies – Pipeline Products by Stage of Development 19

4.2 Electrophysiology Ablation Catheters – Pipeline Products by Stage of Development 21

5 Electrophysiology Ablation Catheters Companies and Product Overview 23

5.1 Ablacon Inc Company Overview 23

5.1.1 Ablacon Inc Pipeline Products & Ongoing Clinical Trials Overview 23

5.2 Acotec Scientific Co Ltd Company Overview 24

5.2.1 Acotec Scientific Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 24

5.3 Adagio Medical Inc. Company Overview 27

5.3.1 Adagio Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview 27

5.4 Apama Medical Inc Company Overview 28

5.4.1 Apama Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 28

5.5 APT Medical Inc Company Overview 29

5.5.1 APT Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 29

5.6 Biosense Webster Inc Company Overview 32

5.6.1 Biosense Webster Inc Pipeline Products & Ongoing Clinical Trials Overview 32

5.7 BioTex Inc Company Overview 38

5.7.1 BioTex Inc Pipeline Products & Ongoing Clinical Trials Overview 38

5.8 Boston Scientific Corp Company Overview 39

5.8.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 39

5.9 CardioFocus Inc Company Overview 45

5.9.1 CardioFocus Inc Pipeline Products & Ongoing Clinical Trials Overview 45

5.10 CardioNova Ltd Company Overview 48

5.10.1 CardioNova Ltd Pipeline Products & Ongoing Clinical Trials Overview 48

5.11 CathEffects LLC Company Overview 49

5.11.1 CathEffects LLC Pipeline Products & Ongoing Clinical Trials Overview 49

5.12 CathRx Ltd Company Overview 50

5.12.1 CathRx Ltd Pipeline Products & Ongoing Clinical Trials Overview 50

5.13 Cibiem, Inc. Company Overview 53

5.13.1 Cibiem, Inc. Pipeline Products & Ongoing Clinical Trials Overview 53

5.14 Columbia University Company Overview 54

5.14.1 Columbia University Pipeline Products & Ongoing Clinical Trials Overview 54

5.15 Cordis Corp Company Overview 55

5.15.1 Cordis Corp Pipeline Products & Ongoing Clinical Trials Overview 55

5.16 CoreMap Inc Company Overview 56

5.16.1 CoreMap Inc Pipeline Products & Ongoing Clinical Trials Overview 56

5.17 Coridea, LLC Company Overview 57

5.17.1 Coridea, LLC Pipeline Products & Ongoing Clinical Trials Overview 57

5.18 CryoTherapeutics Gmbh Company Overview 58

5.18.1 CryoTherapeutics Gmbh Pipeline Products & Ongoing Clinical Trials Overview 58

5.19 Epicardial Technologies Inc (Inactive) Company Overview 61

5.19.1 Epicardial Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 61

5.20 Ethicon US LLC Company Overview 62

5.20.1 Ethicon US LLC Pipeline Products & Ongoing Clinical Trials Overview 62

5.21 Farapulse Inc Company Overview 63

5.21.1 Farapulse Inc Pipeline Products & Ongoing Clinical Trials Overview 63

5.22 FocusStart LLC Company Overview 66

5.22.1 FocusStart LLC Pipeline Products & Ongoing Clinical Trials Overview 66

5.23 Galvanize Therapeutics Inc Company Overview 67

5.23.1 Galvanize Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 67

5.24 Hansen Medical Inc (Inactive) Company Overview 70

5.24.1 Hansen Medical Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 70

5.25 Hyblate Medical Company Overview 71

5.25.1 Hyblate Medical Pipeline Products & Ongoing Clinical Trials Overview 71

5.26 Imricor Medical Systems Inc Company Overview 72

5.26.1 Imricor Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 72

5.27 Interventional Imaging, Inc. Company Overview 76

5.27.1 Interventional Imaging, Inc. Pipeline Products & Ongoing Clinical Trials Overview 76

5.28 Iowa Approach Inc. Company Overview 77

5.28.1 Iowa Approach Inc. Pipeline Products & Ongoing Clinical Trials Overview 77

5.29 Japan Lifeline Co Ltd Company Overview 80

5.29.1 Japan Lifeline Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 80

5.30 Maestro Heart SA Company Overview 81

5.30.1 Maestro Heart SA Pipeline Products & Ongoing Clinical Trials Overview 81

5.31 Medlumics SL Company Overview 82

5.31.1 Medlumics SL Pipeline Products & Ongoing Clinical Trials Overview 82

5.32 Medtronic Plc Company Overview 83

5.32.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview 83

5.33 MedWaves Inc Company Overview 84

5.33.1 MedWaves Inc Pipeline Products & Ongoing Clinical Trials Overview 84

5.34 MicroPort Scientific Corp Company Overview 85

5.34.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 85

5.35 Northwestern University Company Overview 87

5.35.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 87

5.36 Novasentis Inc Company Overview 88

5.36.1 Novasentis Inc Pipeline Products & Ongoing Clinical Trials Overview 88

5.37 OrbusNeich Company Overview 89

5.37.1 OrbusNeich Pipeline Products & Ongoing Clinical Trials Overview 89

5.38 SCR, Inc. Company Overview 90

5.38.1 SCR, Inc. Pipeline Products & Ongoing Clinical Trials Overview 90

5.39 Seattle Children’s Hospital Company Overview 91

5.39.1 Seattle Children’s Hospital Pipeline Products & Ongoing Clinical Trials Overview 91

5.40 Shanghai HeartCare Medical Technology Co Ltd Company Overview 92

5.40.1 Shanghai HeartCare Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 92

5.41 Shanghai MicroPort EP MedTech Co Ltd Company Overview 93

5.41.1 Shanghai MicroPort EP MedTech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 93

5.42 St. Jude Medical LLC Company Overview 97

5.42.1 St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 97

5.43 Stereotaxis Inc Company Overview 100

5.43.1 Stereotaxis Inc Pipeline Products & Ongoing Clinical Trials Overview 100

5.44 University of Arkansas at Little Rock Company Overview 104

5.44.1 University of Arkansas at Little Rock Pipeline Products & Ongoing Clinical Trials Overview 104

5.45 University of Michigan Company Overview 105

5.45.1 University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 105

5.46 University of Rochester Company Overview 106

5.46.1 University of Rochester Pipeline Products & Ongoing Clinical Trials Overview 106

5.47 University of Texas Medical Branch at Galveston Company Overview 107

5.47.1 University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview 107

5.48 Vanderbilt University Company Overview 108

5.48.1 Vanderbilt University Pipeline Products & Ongoing Clinical Trials Overview 108

5.49 Vimecon GmbH Company Overview 109

5.49.1 Vimecon GmbH Pipeline Products & Ongoing Clinical Trials Overview 109

5.50 Vivonics Inc Company Overview 110

5.50.1 Vivonics Inc Pipeline Products & Ongoing Clinical Trials Overview 110

5.51 Voyage Medical (Inactive) Company Overview 111

5.51.1 Voyage Medical (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 111

6 Electrophysiology Ablation Catheters- Recent Developments 112

6.1 Sep 21, 2023: Microport Scientific Corp. Announces 2023 Interim Report 112

6.2 Sep 01, 2023: Japan Lifeline Announces Changes in Organizations and Personnel 114

6.3 Aug 26, 2023: Medtronic Q2 2024 Earnings Estimates Increased by William Blair 114

6.4 Aug 17, 2023: Mayo Clinic Reports Strong Finances for 2023 So Far with Q2 Revenue of $4.47 billion 114

6.5 Aug 11, 2023: Kristin Peck, CEO of Zoetis, to join Mayo Clinic Board of Trustees 114

6.6 Aug 08, 2023: Medtronic to Announce Financial Results for its First Quarter of Fiscal Year 2024 115

6.7 Jul 19, 2023: Boston Scientific lays off 52 workers as it closes another Silicon Valley facility 115

6.8 Jul 19, 2023: Boston Scientific Lays off 52 Amid California Facility Closure 115

6.9 Jul 18, 2023: Imricor Receives US$1 Million Commitment Letter from North Dakota Development Fund 115

6.10 Jul 11, 2023: Microport Scientific Provides Consolidated Earnings Guidance for the Six Months Ended June 30, 2023 116

6.11 May 11, 2023: Medtronic to announce financial results for its fourth quarter and full fiscal year 2023 116

6.12 May 09, 2023: GE HealthCare Names James Saccaro Vice President and Chief Financial Officer 116

6.13 Apr 26, 2023: MicroPort announces annual results for 2022 117

6.14 Apr 25, 2023: Cryofocus Medtech Shanghai Co. Announces 2022 Annual Report 117

6.15 Apr 12, 2023: Medtronic has a layoff in California 118

6.16 Mar 16, 2023: Medtronic joins in $25M funding round for home monitoring company 118

6.17 Feb 01, 2023: Japan Lifeline Announces Consolidated Financial Results for the Nine months Ended December 31, 2022 118

6.18 Jan 30, 2023: GE HealthCare Reports Fourth Quarter and Full Year 2022 Financial Results 119

6.19 Jan 17, 2023: GE HealthCare to Announce Fourth Quarter and Full Year 2022 Results on January 30, 2023 122

6.20 Jan 10, 2023: GE HealthCare Announces Preliminary Fourth Quarter and Full Year 2022 Revenue Results; Introduces 2023 Outlook 122

6.21 Jan 05, 2023: GE HealthCare appoints former Amazon exec as first chief technology officer 123

6.22 Nov 23, 2022: Medtronic Reports Quarterly Earnings 123

6.23 Nov 22, 2022: Medtronic reports second quarter fiscal 2023 financial results 123

6.24 Nov 22, 2022: Mayo Clinic surgeon takes the wheel as Kwik Trip’s new CEO 129

6.25 Nov 15, 2022: Medtronic Set to Announce Earnings on Tuesday 129

6.26 Nov 07, 2022: National study suggests it’s time to rethink how we treat atrial fibrillation 129

7 Appendix 131

7.1 Methodology 131

7.2 About GlobalData 134

7.3 Contact Us 134

7.4 Disclaimer 134

Frequently asked questions

Electrophysiology Ablation Catheters Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies thematic reports
Currency USD
$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Electrophysiology Ablation Catheters Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Electrophysiology Ablation Catheters Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies in real time.

  • Access a live Electrophysiology Ablation Catheters Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.